Refine
Has Fulltext
- yes (133)
Is part of the Bibliography
- yes (133)
Year of publication
Document Type
- Journal article (95)
- Doctoral Thesis (37)
- Preprint (1)
Language
- English (133) (remove)
Keywords
- 3D printing (14)
- melt electrowriting (14)
- additive manufacturing (12)
- biofabrication (11)
- melt electrospinning writing (8)
- Hydrogel (7)
- hyaluronic acid (7)
- tissue engineering (7)
- bioprinting (6)
- polycaprolactone (6)
- 3D-Druck (5)
- bioink (5)
- hydrogels (5)
- Biofabrication (4)
- Polymere (4)
- Tissue Engineering (4)
- biomaterials (4)
- extracellular matrix (4)
- hydrogel (4)
- magnesium phosphate cement (4)
- melt electrowriting (MEW) (4)
- phytic acid (4)
- scaffold (4)
- thiol-ene (4)
- Biomaterial (3)
- Calciumphosphate (3)
- Knochenzement (3)
- angiogenesis (3)
- bone (3)
- breast cancer (3)
- calcium phosphate cement (3)
- chondrogenic differentiation (3)
- electrohydrodynamic (3)
- electrohydrodynamics (3)
- 3D powder printing (2)
- Biofabrikation (2)
- Calciumphosphat (2)
- Cement (2)
- Dihydrooxazole (2)
- Electrospinning (2)
- Fluorescence Microscopy (2)
- Gelatine (2)
- Knochenersatz (2)
- MSC (2)
- Melt Electrowriting (2)
- Melt electrowriting (2)
- Nanopartikel (2)
- Oberflächenfunktionalisierung (2)
- Polyethylenglykole (2)
- Polyoxazoline (2)
- Ringöffnungspolymerisation (2)
- Tissue engineering (2)
- Zement (2)
- arteriovenous loop (2)
- axial vascularization (2)
- baghdadite (2)
- bioceramic (2)
- biocompatibility (2)
- bioinorganic (2)
- biomedical materials (2)
- bone adhesive (2)
- bone cement (2)
- calcium phosphate (2)
- cartilage (2)
- cortical neurons (2)
- dual setting (2)
- dual setting system (2)
- dual-stage crosslinking (2)
- fiber reinforcement (2)
- focal adhesions (2)
- in vitro (2)
- inflammation (2)
- mechanical properties (2)
- polymer processing (2)
- polymer-peptide-conjugate (2)
- printability (2)
- rheology (2)
- shape fidelity (2)
- therapy (2)
- (AB)\(_{n}\) segmented copolymers (1)
- 2-Aminoethylphosphonic acid (1)
- 316L stainless-steel (1)
- 3D Bioprinting (1)
- 3D Printing (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D neuronal networks (1)
- 3D scaffolds (1)
- 3D tumor model (1)
- ACPC (1)
- ALI culture (1)
- Additive Fertigung (1)
- Adenovirus (1)
- Adhäsion (1)
- Adipose Tissue (1)
- Anisotropic structures (1)
- Arteriosklerose (1)
- Artery Models (1)
- Aspergillose (1)
- Aspergillosis (1)
- Atherosclerosis (1)
- Baghdadite (1)
- Beschichtung (1)
- Biofabrication of hydrogels (1)
- Bioink (1)
- Biologischer Abbau (1)
- Blockcopolymere (1)
- Bone marrow (1)
- Bone-replacement (1)
- Breast cancer (1)
- Ca\(^{2+}\)-Imaging (1)
- Calcium Phosphate (1)
- Calcium phosphate (1)
- Calcium phosphate-based biomaterials (1)
- Calciumhydroxid (1)
- Calciumphosphatzemente (1)
- Cartilage (1)
- Cell Sheet Engineering (1)
- Cell adhesion (1)
- Ceramic polymer composite (1)
- Chelatbildner (1)
- Chemical modification of biopolymers (1)
- Chondrogenesis (1)
- Chondrogenic differentiation (1)
- Chondrozyten (1)
- Colloidal Stability (1)
- Correlative microscopy (1)
- Dectin-1 (1)
- Degradation (1)
- Dual setting system (1)
- Dual-setting (1)
- ECM (1)
- Elektrospinnen (1)
- Elektrostatisches Verspinnen (1)
- Extrazelluläre Matrix (1)
- Fettgewebe (1)
- Fibrin (1)
- Fibroblasten (1)
- FluidFM (1)
- FluidFM technology (1)
- Freezing (1)
- Functional hydrophilic polymers (1)
- Funktionalisierung <Chemie> (1)
- Funktionalisierung von elektrogesponnenen Fasern (1)
- Gefrierstrukturierung (1)
- Gelatin (1)
- Gene therapy (1)
- Gerichtete Erstarrung (1)
- Gewebe (1)
- Geweberegeneration (1)
- Glycidol (1)
- Gold-Nanoparticles (1)
- HA modifiedCNF membranes (1)
- HASH (1)
- HEMA (1)
- Hemodynamics (1)
- Hyaluronic Acid (1)
- Hyaluronsäure (1)
- Hydrogele (1)
- Hydrogels (1)
- Hypertrophy (1)
- Hämodynamik (1)
- IP6 (1)
- Implantat (1)
- In vitro model (1)
- Injectability (1)
- Iron Oxide Nanoparticles (1)
- Isocyanate (1)
- Janus fibers (1)
- Knochen (1)
- Knochenkleber (1)
- Knochenwachs (1)
- Knochenzemente (1)
- Knorpel (1)
- Konjugate (1)
- Korrelative Mikroskopie (1)
- MPI (1)
- MPS (1)
- MRI (1)
- Macrophage extracellular traps (1)
- Magnesiumphosphate (1)
- Makrophagen (1)
- Melt electrospinning (1)
- Mesenchymal stem cell (1)
- Modification (1)
- Modifikation von Biokeramiken (1)
- Morphology (1)
- Mucin (1)
- Multifunctionalisability (1)
- Muzin (1)
- NCO-sP(EO-stat-PO) (1)
- NLRP3 (1)
- Nanofaser (1)
- Nanogels (1)
- Nanoröhre (1)
- Nanotubular coatings (1)
- Nanotubuläre Beschichtungen (1)
- Normal breast (1)
- Oxygen diffusion hardening (1)
- PCL (1)
- PEG (1)
- PLGA (1)
- PTEN (1)
- PVD Beschichtung (1)
- PVD coatings (1)
- PVD-Verfahren (1)
- Poly(2-oxazoline) (1)
- Poly(glycidol)s (1)
- Polycaprolacton (1)
- Polylactid-co-Glycolid (1)
- Polymer-peptide-conjugate (1)
- Polymers (1)
- Polymilchsäure (1)
- Polyoxazolines (1)
- Primary cell lines (1)
- QCM (1)
- RAFT (1)
- RHO (1)
- ROCK (1)
- Rapid Prototyping <Fertigung> (1)
- Regeneration (1)
- Rheology (1)
- Rho GTPases (1)
- SOX9 (1)
- Sauerstoffdiffusionshärtung (1)
- Scaffold (1)
- Scaffold <Tissue Engineering> (1)
- Schiff base chemistry (1)
- Schleuderguss (1)
- Setting Control (1)
- Silica precursor (1)
- Sol-gel (1)
- Staphylococcus aureus / drug effects (1)
- Star-shaped poly(ethylene glycol) (1)
- Stem cells plasticity (1)
- Sternpolymere (1)
- Tantal (1)
- Therapeutisches System (1)
- Thermoresponsive Polymere (1)
- Thioether-Poly(glycidol) (1)
- Ti(Ag) Beschichtungen (1)
- Ti(Ag) coatings (1)
- Unidirectional Freezing (1)
- Vancomycin / administration & dosage (1)
- Vancomycin / chemistry (1)
- Vancomycin / pharmacology (1)
- Vascularization (1)
- Vaskularisation (1)
- Verbundwerkstoff (1)
- WST test (1)
- Wasserlösliche Polymere (1)
- Wirkstoff-Träger-System (1)
- Wirkstofffreisetzung (1)
- ZIP (1)
- acrylate-endcapped urethane-based polymer (AUP) (1)
- actin (1)
- acute myeloid leukaemia (1)
- adhesion dynamics (1)
- adipose tissue (1)
- adipose tissue engineering (1)
- adipose-derived stromal cells (1)
- agarose (1)
- alginate (1)
- alveolar‐capillary barrier (1)
- amoeboid cell migration (1)
- animal model (1)
- anisotropic porous structures (1)
- anti-bacterial agents / administration & dosage (1)
- anti-bacterial agents / chemistry (1)
- anti-bacterial agents / pharmacology (1)
- antibacterial (1)
- antibakteriell (1)
- arthritis (1)
- artificial bones (1)
- astrocytes (1)
- atomic force microscopy (1)
- azlactone (1)
- balloon kyphoplasty (1)
- bending strength (1)
- bio-printability (1)
- bioceramics (1)
- biocompatible Materials (1)
- biodegradable polymer (1)
- biodegradable polymers (1)
- biofabricated vascular graft (1)
- bioinspired interface (1)
- bioinspired membrane (1)
- biological models (1)
- biomaterial ink (1)
- biomaterials – cells (1)
- biomechanical evaluation (1)
- biomechanics (1)
- biomedical engineering (1)
- biomimetic scaffolds (1)
- biophysics (1)
- biosensor (1)
- biosensors (1)
- blood-plasma (1)
- bohrbar (1)
- bone and cartilage tissue engineering (1)
- bone critical size defect (1)
- bone graft substitutes (1)
- bone replacement material (1)
- bone wax (1)
- bone wires (1)
- brain cancer (1)
- breast cancer model (1)
- brushite cement (1)
- calcaneus (1)
- calcium phosphate cements (1)
- calcium-phosphate (1)
- calciumhydroxide (1)
- carbon fiber reinforcement (1)
- carbon nanotube microspheres (1)
- cardiovascular pharmacology (1)
- cartilage repair (1)
- cavitation (1)
- cell coagulation (1)
- cell counting (1)
- cell elongation (1)
- cell guidance (1)
- cell migration (1)
- cell morphology (1)
- cell printing (1)
- cell self-assembled monolayers (1)
- cell transplantation (1)
- cell viability (1)
- cement (1)
- centrifugally casting (1)
- ceramic polymer composite (1)
- ceramics (1)
- chemical crosslinking (1)
- chemical engineering (1)
- chemokines (1)
- chemoselective (1)
- chemosensitivity (1)
- chondrocyte (1)
- chondrocytes (1)
- chondroprogenitors (1)
- click chemistry (1)
- co-culture (1)
- coating (1)
- coatings (1)
- cochlea (1)
- collagen (1)
- collagen sponge (1)
- combination of physical vapor deposition and electrochemical etching (1)
- composite material (1)
- compressive strength (1)
- connective tissue (1)
- crimp structure (1)
- crosslinked coating (1)
- cryostructured scaffolds (1)
- cyclic mechanical stretch (1)
- cyclic stretch (1)
- cyclic testing (1)
- cyto-compatibility (1)
- cytotoxicity (1)
- damage tolerant cement (1)
- deafness (1)
- defects (1)
- defined humanized test system (1)
- definition (1)
- degradable bone substitutes (1)
- degradable implant (1)
- degradation (1)
- detachment force quantification (1)
- dicalcium phosphate cement (1)
- differentation (1)
- digitization (1)
- dihydrate cement (1)
- directional solidification (1)
- disease models (1)
- drillability (1)
- drillable (1)
- drillable bone cement (1)
- drop on demand (1)
- drug delivery (1)
- drug liberation (1)
- drug release (1)
- dual abbindend (1)
- durotaxis (1)
- electroactive (1)
- electroactive polymers (1)
- electrohydrodynamic printing (1)
- electron microscopy (1)
- electrospinning (1)
- electrospun fibers (1)
- eletrhydrodynamic (1)
- embedded templating (1)
- endothelial progenitor cells (1)
- expression (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- extrusion-based 3D printing (1)
- factor-I (1)
- farringtonite (1)
- fiber (1)
- fibers (1)
- fiber–matrix interaction (1)
- filopodia (1)
- fixation (1)
- fluidics (1)
- force (1)
- fracture (1)
- free radical polymerization (1)
- functionalization (1)
- funktionale Präpolymere (1)
- gels (1)
- gels and hydrogels (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- granular inks (1)
- granulare Tinten (1)
- granules (1)
- growth (1)
- guided bone regeneration (1)
- heart-failure (1)
- hemocompatibility (1)
- heterotypic scaffold design (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human macrophages (1)
- human neutrophil elastase (HNE) (1)
- hybrid fabrication (1)
- hybrid materials (1)
- hybrid polymers (1)
- hydraulic reactivity (1)
- hydrogel formation (1)
- hydrophilic polymers (1)
- hydroxyapatite (1)
- hypoxia (1)
- imaging agents (1)
- immunomodulation (1)
- implant (1)
- implants (1)
- in vitro cell‐stretch model (1)
- in-vivo Micro-Computed Tomography (1)
- inflammatory response (1)
- inner ear (1)
- inositol hexaphosphate (1)
- intercellular adhesion (1)
- interface control (1)
- iron release (1)
- lamellipodia (1)
- lectin (1)
- left-ventricular function (1)
- load to failure testing (1)
- lung cell model (1)
- macrophage polarization (1)
- macrophages (1)
- magnetic properties (1)
- magnetoactive materials (1)
- material-host interactions (1)
- materials for optics (1)
- materials testing (1)
- mature cell-cell contacts (1)
- mechanical activation (1)
- mechanical performance (1)
- mechanical reinforcement (1)
- medical device (1)
- medical-grade poly(ε-caprolactone) (1)
- medicine (1)
- melanoma (1)
- melt electrowriting (1)
- melt electrofibrillation (1)
- melt electrospinning (1)
- mesenchymal stem cells (1)
- microfibers (1)
- microfibres (1)
- microfluidics (1)
- microstructures (1)
- microvasculature (1)
- migration (1)
- minipig (1)
- modelling (1)
- morphology controls (1)
- mucin (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- myosin-II (1)
- nanofibers (1)
- nanostructures (1)
- nanotopographical surfaces (1)
- native chemical ligation (1)
- networks (1)
- neurite growth (1)
- organ-on-a-chip (1)
- organoids (1)
- osseointegration (1)
- osteoblasts (1)
- osteochondral defect (1)
- osteogenesis (1)
- osteoporosis (1)
- oxidation (1)
- oxygen reduction reaction (1)
- particle study (1)
- peptide conjugation (1)
- peptide immobilization (1)
- phase conversion (1)
- photo-cross-linkable elastomer (1)
- photo-crosslinking (1)
- photopolymerization (1)
- physicochemical characterization (1)
- plasticizers (1)
- platelet-adhesion (1)
- platelets (1)
- platinum nanostructures (1)
- poly(2-ethyl-2-oxazoline) (1)
- poly(2-oxazoline)s (1)
- poly(ethylene glycol) (1)
- poly(glycidol) (1)
- poly(lactic-co-glycolic acid) (1)
- poly(lactide-co-glycolide) (1)
- polyacrylic acid (1)
- polyethylene glycol (1)
- polyethylenglykole (1)
- polyglycidol (1)
- polylactid (1)
- polymer (1)
- polymer-analogue functionalization (1)
- polymeric matrix (1)
- polymers (1)
- polyoxazoline (1)
- polyoxazolines (1)
- porosity (1)
- postsurgical adhesion (1)
- pre-crosslinking (1)
- premixed (1)
- primary vascular smooth muscle‐like cells (vSMCs) (1)
- proliferation (1)
- prostheses and implants (1)
- protein adsorption (1)
- präfabriziert (1)
- radiopacity (1)
- rat model (1)
- recruitment (1)
- remodelling (1)
- repair (1)
- rhBMP–2 (1)
- ring opening polymerisation (1)
- ring-opening polymerization (1)
- sPEG (1)
- sacrificial printing (1)
- sanders (1)
- scaffold design (1)
- scaffolds (1)
- screw (1)
- self-assembled monolayers (1)
- serial block face EM (1)
- setting reaction (1)
- shear stress (1)
- shear thinning (1)
- signaling (1)
- silicones (1)
- sodium alginate (1)
- solution electrospinning (1)
- spheroids (1)
- spinning (1)
- stanfieldite (1)
- starPEG (1)
- starPEG hydrogel (1)
- stem cells (1)
- stimulation (1)
- stress (1)
- subcutaneous implanation (1)
- sugar glass printing (1)
- surface coating (1)
- surface functionalisation (1)
- surface functionalization (1)
- surfaces (1)
- sutures (1)
- synbones (1)
- synergistic reinforcement (1)
- synthetic hydrogels (1)
- systematic investigations (1)
- tension (1)
- tethering (1)
- thermoresponsive hydrogel (1)
- thrombin (1)
- thrombosis (1)
- tibial head depression fracture (1)
- tissue morphogenesis (1)
- tissue regeneration (1)
- toe region mechanical behaviour (1)
- topotaxis (1)
- total joint arthroplasty (1)
- total knee arthroplasty (1)
- traction (1)
- tranexamic acid (1)
- transforming growth factor-beta 1 (1)
- transplantation (1)
- tubular constructs (1)
- tumor heterogeneity (1)
- tunable ultra‐thin biphasic membrane (1)
- unidirectional freezing (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- x-ray micro computed tomography (1)
- zinc (1)
- zonal (1)
- zonal construct (1)
- α-tricalcium phosphate (1)
Institute
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (133) (remove)
Sonstige beteiligte Institutionen
The reliability of implantable blood sensors is often hampered by unspecific adsorption of plasma proteins and blood cells. This not only leads to a loss of sensor signal over time, but can also result in undesired host vs. graft reactions. Within this study we evaluated the hemocompatibility of isocyanate conjugated star shaped polytheylene oxide-polypropylene oxide co-polymers NCO-sP(EO-stat-PO) when applied to gold surfaces as an auspicious coating material for gold sputtered blood contacting sensors. Quartz crystal microbalance (QCM) sensors were coated with ultrathin NCO-sP(EO-stat-PO) films and compared with uncoated gold sensors. Protein resistance was assessed by QCM measurements with fibrinogen solution and platelet poor plasma (PPP), followed by quantification of fibrinogen adsorption. Hemocompatibility was tested by incubation with human platelet rich plasma (PRP). Thrombin antithrombin-III complex (TAT), beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) were used as coagulation activation markers. Furthermore, scanning electron microscopy (SEM) was used to visualize platelet adhesion to the sensor surfaces. Compared to uncoated gold sensors, NCO-sP(EO-stat-PO) coated sensors revealed significant better resistance against protein adsorption, lower TAT generation and a lower amount of adherent platelets. Moreover, coating with ultrathin NCO-sP(EO-stat-PO) films creates a cell resistant hemocompatible surface on gold that increases the chance of prolonged sensor functionality and can easily be modified with specific receptor molecules.
This thesis concerned the design and examination of a scaffold for tissue engineering applications. The template for the presented scaffold came from nature itself: the intercellular space in tissues that provides structure and support to the cells of the respective tissue, known as extracellular matrix (ECM). Fibres are a predominant characteristic feature of ECM, providing adhesion sites for cell-matrix interactions. In this dissertation a fibrous mesh was generated using the electrospinning technique to mimic the fibrous structure of the ECM. Two base polymers were explored: a biodegradable polyester, poly(D,L-lactide-co-glycolide); and a functional PEG-based star polymer, NCO-sP(EO-stat-PO). This topic was described in three major parts: the first part was materials based, concerning the chemical design and characterisation of the polymer scaffolds; the focus was then shifted to the cellular response to this fibrous scaffold; and finally the in vivo performance of the material was preliminarily assessed. The first steps towards an electrospun mesh started with adjusting the spinning parameters for the generation of homogeneous fibres. As reported in Chapter 3 a suitable setup configuration was on the one hand comprised of a spinning solution that consisted of 28.5 w/v% PLGA RG 504 and 6 w/v% NCO-sP(EO-stat-PO) in 450 µL acetone, 50 µL DMSO and 10 µL of an aqueous trifluoroacetic acid solution. On the other hand an ideal spinning behaviour was achieved at process parameters such as a flow rate of 0.5 mL/h, spinneret to collector distance of 12-16 cm and a voltage of 13 kV. The NCO-sP(EO-stat-PO) containing fibres proved to be highly hydrophilic as the functional additive was present on the fibre surface. Furthermore, the fibres featured a bulk degradation pattern as a consequence of the proportion of PLGA. Besides the morphologic similarity to ECM fibres, the functionality of the electrospun fibres is also decisive for a successful ECM mimicry. In Chapter 4, the passive as well as active functionality of the fibres was investigated. The fibres were required to be protein repellent to prevent an unspecific cell adhesion. This was proven as even 6.5 % sP(EO-stat-PO) in the PLGA fibres reduced any unspecific protein adsorption of bovine serum albumin and foetal calf serum to less than 1 %. However, avidin based proteins attached to the fibres. This adhesion process was avoided by an additional fibre surface treatment with glycidol. The active functionalisation of NCO-sP(EO-stat-PO)/PLGA fibres was investigated with two fluorescent dyes and biocytin. A threefold, chemically orthogonal, fibre modification was achieved with these dyes. The chapters about the chemical and mechanical properties laid the basis for the in vitro chapters where a specific fibre functionalisation with peptides was conducted to analyse the cell adhesion and biochemical expressions. Beginning with fibroblasts in Chapter 5 the focus was on the specific cell adhesion on the electrospun fibres. While NCO-sP(EO-stat-PO)/PLGA fibres without peptides did not allow any adhesion of fibroblasts, a fibre modification with GRGDS (an adhesion mediating peptide sequence) induced the adhesion and spreading of human dermal fibroblasts on the fibrous scaffolds. The control sequence GRGES that has no adhesion mediating qualities did not lead to any cell adhesion as observed on fibres without modifications. While the experiments of Chapter 5 were a proof-of-concept, in Chapter 6 a possible application in cartilage tissue engineering was examined. Therefore, primary human chondrocytes were seeded on fibrous scaffolds with various peptide sequences. Though the chondrocytes exhibited high viability on all scaffolds, an active interaction of cells and fibres was only found for the decorin derived sequence CGKLER. Live-cell-imaging revealed both cell attachment and migration within CGKLER-modified meshes. As chondrocytes undergo a de-differentiation towards a fibroblast-like phenotype, the chondrogenic re-differentiation on these scaffolds was investigated in a long term cell culture experiment of 28 days. Therefore, the glycosaminoglycan production was analysed as well as the mRNA expression of genes coding for collagen I and II, aggrecan and proteoglycan 4. In general only low amounts of the chondrogenic markers were measured, suggesting no chondrogenic differentiation. For conclusive evidence follow-up experiments are required that support or reject the findings. The success of an implant for tissue engineering relies not only on the response of the targeted cell type but also on the immune reaction caused by leukocytes. Hence, Chapter 7 dealt with primary human macrophages and their behaviour and phenotype on two-dimensional (2D) surfaces compared to three-dimensional (3D) fibrous substrates. It was found that the general non-adhesiveness of NCO-sP(EO-stat-PO) surfaces and fibres does not apply to macrophages. The cells aligned along the fibres on surfaces or resided in the pores of the meshes. On flat surfaces without 3D structure the macrophages showed a retarded adhesion kinetic accompanied with a high migratory activity indicating their search for a topographical feature to adhere to. Moreover, a detailed investigation of cell surface markers and chemokine signalling revealed that macrophages on 2D surfaces exhibited surface markers indicating a healing phenotype while the chemokine release suggested a pro-inflammatory phenotype. Interestingly, the opposite situation was found on 3D fibrous substrates with pro-inflammatory surface markers and pro-angiogenic cytokine release. As the immune response largely depends on cellular communication, it was concluded that the NCO-sP(EO-stat-PO)/PLGA fibres induce an adequate immune response with promising prospects to be used in a scaffold for tissue engineering. The final chapter of this thesis reports on a first in vivo study conducted with the presented electrospun fibres. Here, the fibres were combined with a polypropylene mesh for the treatment of diaphragmatic hernias in a rabbit model. Two scaffold series were described that differed in the overall surface morphology: while the fibres of Series A were incorporated into a thick gel of NCO-sP(EO-stat-PO), the scaffolds of Series B featured only a thin hydrogel layer so that the overall fibrous structure could be retained. After four months in vivo the treated defects of the diaphragm were significantly smaller and filled mainly with scar tissue. Thick granulomas occurred on scaffolds of Series A while the implants of Series B did not induce any granuloma formation. As a consequence of the generally positive outcome of this study, the constructs were enhanced with a drug release system in a follow-up project. The incorporated drug was the MMP-inhibitor Ilomastat which is intended to reduce the formation of scar tissue. In conclusion, the simple and straight forward fabrication, the threefold functionalisation possibility and general versatile applicability makes the meshes of NCO-sP(EO-stat-PO)/PLGA fibres a promising candidate to be applied in tissue engineering scaffolds in the future.
Adipose tissue defects and related pathologies still represent major challenges in reconstructive surgery. Based on to the paradigm ‘replace with alike’, adipose tissue is considered the ideal substitute material for damaged soft tissue [1-3]. Yet the transfer of autologous fat, particularly larger volumes, is confined by deficient and unpredictable long term results, as well as considerable operative morbidity at the donor and recipient site [4-6], calling for innovative treatment options to improve patient care.
With the aim to achieve complete regeneration of soft tissue defects, adipose tissue engineering holds great promise to provide functional, biologically active adipose tissue equivalents. Here, especially long-term maintenance of volume and shape, as well as sufficient vascularization of engineered adipose tissue represent critical and unresolved challenges [7-9]. For adipose tissue engineering approaches to be successful, it is thus essential to generate constructs that retain their initial volume in vivo, as well as to ensure their rapid vascularization to support cell survival and differentiation for full tissue regeneration [9,10]. Therefore, it was the ultimate goal of this thesis to develop volume-stable 3D adipose tissue constructs and to identify applicable strategies for sufficient vascularization of engineered constructs. The feasibility of the investigated approaches was verified by translation from in vitro to in vivo as a critical step for the advancement of potential regenerative therapies.
For the development of volume-stable constructs, the combination of two biomaterials with complementary properties was successfully implemented. In contrast to previous approaches in the field using mainly non-degradable solid structures for mechanical protection of developing adipose tissue [11-13], the combination of a cell-instructive hydrogel component with a biodegradable porous support structure of adequate texture was shown advantageous for the generation of volume-stable adipose tissue. Specifically, stable fibrin hydrogels previously developed in our group [14] served as cell carrier and supported the adipogenic development of adipose-derived stem cells (ASCs) as reflected by lipid accumulation and leptin secretion. Stable fibrin gels were thereby shown to be equally supportive of adipogenesis compared to commercial TissuCol hydrogels in vitro. Using ASCs as a safe source of autologous cells [15,16] added substantial practicability to the approach. To enhance the mechanical strength of the engineered constructs, porous biodegradable poly(ε caprolactone)-based polyurethane (PU) scaffolds were introduced as support structures and shown to exhibit adequately sized pores to host adipocytes as well as interconnectivity to allow coherent tissue formation and vascularization. Low wettability and impaired cell attachment indicated that PU scaffolds alone were insufficient in retaining cells within the pores, yet cytocompatibility and differentiation of ASCs were adequately demonstrated, rendering the PU scaffolds suitable as support structures for the generation of stable fibrin/PU composite constructs (Chapter 3).
Volume-stable adipose tissue constructs were generated by seeding the pre-established stable fibrin/PU composites with ASCs. Investigation of size and weight in vitro revealed that composite constructs featured enhanced stability relative to stable fibrin gels alone. Comparing stable fibrin gels and TissuCol as hydrogel components, it was found that TissuCol gels were less resilient to degradation and contraction. Composite constructs were fully characterized, showing good cell viability of ASCs and strong adipogenic development as indicated by functional analysis via histological Oil Red O staining of lipid vacuoles, qRT-PCR analysis of prominent adipogenic markers (PPARγ, C/EBPα, GLUT4, aP2) and quantification of leptin secretion. In a pilot study in vivo, investigating the suitability of the constructs for transplantation, stable fibrin/PU composites provided with a vascular pedicle gave rise to areas of well-vascularized adipose tissue, contrasted by insufficient capillary formation and adipogenesis in constructs implanted without pedicle. The biomaterial combination of stable fibrin gels and porous biodegradable PU scaffolds was thereby shown highly suitable for the generation of volume-stable adipose tissue constructs in vivo, and in addition, the effectiveness of immediate vascularization upon implantation to support adipose tissue formation was demonstrated (Chapter 4).
Further pursuing the objective to investigate adequate vascularization strategies for engineered adipose tissue, hypoxic preconditioning was conducted as a possible approach for in vitro prevascularization. In 2D culture experiments, analysis on the cellular level illustrated that the adipogenic potential of ASCs was reduced under hypoxic conditions when applied in the differentiation phase, irrespective of the oxygen tension encountered by the cells during expansion. Hypoxic treatment of ASCs in 3D constructs prepared from stable fibrin gels similarly resulted in reduced adipogenesis, whereas endothelial CD31 expression as well as enhanced leptin and vascular endothelial growth factor (VEGF) secretion indicated that hypoxic treatment indeed resulted in a pro-angiogenic response of ASCs. Especially the observed profound regulation of leptin production by hypoxia and the dual role of leptin as adipokine and angiogenic modulator were considered an interesting connection advocating further study. Having confirmed the hypothesis that hypoxia may generate a pro-angiogenic milieu inside ASC-seeded constructs, faster vessel ingrowth and improved vascularization as well as an enhanced tolerance of hypoxia-treated ASCs towards ischemic conditions upon implanatation may be expected, but remain to be verified in rodent models in vivo (Chapter 5).
Having previously been utilized for bone and cartilage engineering [17-19], as well as for revascularization and wound healing applications [20-22], stromal-vascular fraction (SVF) cells were investigated as a novel cell source for adipose tissue engineering. Providing cells with adipogenic differentiation as well as vascularization potential, the SVF was applied with the specific aim to promote adipogenesis and vascularization in engineered constructs in vivo. With only basic in vitro investigations by Lin et al. addressing the SVF for adipose repair to date [23], the present work thoroughly investigated SVF cells for adipose tissue construct generation in vitro, and in particular, pioneered the application of these cells for adipose tissue engineering in vivo.
Initial in vitro experiments compared SVF- and ASC-seeded stable fibrin constructs in different medium compositions employing preadipocyte (PGM-2) and endothelial cell culture medium (EGM-2). It was found that a 1:1 mixture of PGM-2 and EGM-2, as previously established for co-culture models of adipogenesis [24], efficiently maintained cells with adipogenic and endothelial potential in SVF-seeded constructs in short and long-term culture setups. Observations on the cellular level were supported by analysis of mRNA expression of characteristic adipogenic and endothelial markers. In preparation of the evaluation of SVF-seeded constructs under in vivo conditions, a whole mount staining (WMS) method, facilitating the 3D visualization of adipocytes and blood vessels, was successfully established and optimized using native adipose tissue as template (Chapter 6).
In a subcutaneous nude mouse model, SVF cells were, for the first time in vivo, elucidated for their potential to support the functional assembly of vascularized adipose tissue. Investigating the effect of adipogenic precultivation of SVF-seeded stable fibrin constructs in vitro prior to implantation on the in vivo outcome, hormonal induction was shown beneficial in terms of adipocyte development, whereas a strong vascularization potential was observed when no adipogenic inducers were added. Via histological analysis, it was proven that the developed structures were of human origin and derived from the implanted cells. Applying SVF cells without precultivation in vitro but comparing two different fibrin carriers, namely stable fibrin and TissuCol gels, revealed that TissuCol profoundly supported adipose formation by SVF cells in vivo. This was contrasted by only minor SVF cell development and a strong reduction of cell numbers in stable fibrin gels implanted without precultivation. Histomorphometric analysis of adipocytes and capillary structures was conducted to verify the qualitative results, concluding that particularly SVF cells in TissuCol were highly suited for adipose regeneration in vivo. Employing the established WMS technique, the close interaction of mature adipocytes and blood vessels in TissuCol constructs was impressively shown and via species-specific human vimentin staining, the expected strong involvement of implanted SVF cells in the formation of coherent adipose tissue was confirmed (Chapter 7).
With the development of biodegradable volume-stable adipose tissue constructs, the application of ASCs and SVF cells as two promising cell sources for functional adipose regeneration, as well as the thorough evaluation of strategies for construct vascularization in vitro and in vivo, this thesis provides valuable solutions to current challenges in adipose tissue engineering. The presented findings further open up new perspectives for innovative treatments to cure soft tissue defects and serve as a basis for directed approaches towards the generation of clinically applicable soft tissue substitutes.
Fibrous tissue growth and loss of residual hearing after cochlear implantation can be reduced by application of the glucocorticoid dexamethasone-21-phosphate-disodium-salt (DEX). To date, sustained delivery of this agent to the cochlea using a number of pharmaceutical technologies has not been entirely successful. In this study we examine a novel way of continuous local drug application into the inner ear using a refillable hydrogel functionalized silicone reservoir. A PEG-based hydrogel made of reactive NCO-sP(EO-stat-PO) prepolymers was evaluated as a drug conveying and delivery system in vitro and in vivo. Encapsulating the free form hydrogel into a silicone tube with a small opening for the drug diffusion resulted in delayed drug release but unaffected diffusion of DEX through the gel compared to the free form hydrogel. Additionally, controlled DEX release over several weeks could be demonstrated using the hydrogel filled reservoir. Using a guinea-pig cochlear trauma model the reservoir delivery of DEX significantly protected residual hearing and reduced fibrosis. As well as being used as a device in its own right or in combination with cochlear implants, the hydrogel-filled reservoir represents a new drug delivery system that feasibly could be replenished with therapeutic agents to provide sustained treatment of the inner ear.
Myocardial infarction (MI) induces a complex inflammatory immune response, followed by the remodelling of the heart muscle and scar formation. The rapid regeneration of the blood vessel network system by the attraction of hematopoietic stem cells is beneficial for heart function. Despite the important role of chemokines in these processes, their use in clinical practice has so far been limited by their limited availability over a long time-span in vivo. Here, a method is presented to increase physiological availability of chemokines at the site of injury over a defined time-span and simultaneously control their release using biodegradable hydrogels. Two different biodegradable hydrogels were implemented, a fast degradable hydrogel (FDH) for delivering Met-CCL5 over 24hrs and a slow degradable hydrogel (SDH) for a gradual release of protease-resistant CXCL12 (S4V) over 4weeks. We demonstrate that the time-controlled release using Met-CCL5-FDH and CXCL12 (S4V)-SDH suppressed initial neutrophil infiltration, promoted neovascularization and reduced apoptosis in the infarcted myocardium. Thus, we were able to significantly preserve the cardiac function after MI. This study demonstrates that time-controlled, biopolymer-mediated delivery of chemokines represents a novel and feasible strategy to support the endogenous reparatory mechanisms after MI and may compliment cell-based therapies.
Designing of implant surfaces using a suitable ligand for cell adhesion to stimulate specific biological responses of stem cells will boost the application of regenerative implants. For example, materials that facilitate rapid and guided migration of stem cells would promote tissue regeneration. When seeded on fibronectin (FN) that was homogeneously immmobilized to NCO-sP(EO-stat-PO), which otherwise prevents protein binding and cell adhesion, human mesenchymal stem cells (MSC) revealed a faster migration, increased spreading and a more rapid organization of different cellular components for cell adhesion on fibronectin than on a glass surface. To further explore, how a structural organization of FN controls the behavior of MSC, adhesive lines of FN with varying width between 10 mu m and 80 mu m and spacings between 5 mu m and 20 mu m that did not allow cell adhesion were generated. In dependance on both line width and gaps, cells formed adjacent cell contacts, were individually organized in lines, or bridged the lines. With decreasing sizes of FN lines, speed and directionality of cell migration increased, which correlated with organization of the actin cytoskeleton, size and shape of the nuclei as well as of focal adhesions. Together, defined FN lines and gaps enabled a fine tuning of the structural organization of cellular components and migration. Microstructured adhesive substrates can mimic the extracellular matrix in vivo and stimulate cellular mechanisms which play a role in tissue regeneration.
Bioactive glass (BG) scaffolds are being investigated for bone tissue engineering applications because of their osteoconductive and angiogenic nature. However, to increase the in vivo performance of the scaffold, including enhancing the angiogenetic growth into the scaffolds, some researchers use different modifications of the scaffold including addition of inorganic ionic components to the basic BG composition. In this study, we investigated the in vitro biocompatibility and bioactivity of Cu2+-doped BG derived scaffolds in either BMSC (bone-marrow derived mesenchymal stem cells)-only culture or co-culture of BMSC and human dermal microvascular endothelial cells (HDMEC). In BMSC-only culture, cells were seeded either directly on the scaffolds (3D or direct culture) or were exposed to ionic dissolution products of the BG scaffolds, kept in permeable cell culture inserts (2D or indirect culture). Though we did not observe any direct osteoinduction of BMSCs by alkaline phosphatase (ALP) assay or by PCR, there was increased vascular endothelial growth factor (VEGF) expression, observed by PCR and ELISA assays. Additionally, the scaffolds showed no toxicity to BMSCs and there were healthy live cells found throughout the scaffold. To analyze further the reasons behind the increased VEGF expression and to exploit the benefits of the finding, we used the indirect method with HDMECs in culture plastic and Cu2+-doped BG scaffolds with or without BMSCs in cell culture inserts. There was clear observation of increased endothelial markers by both FACS analysis and acetylated LDL (acLDL) uptake assay. Only in presence of Cu2+-doped BG scaffolds with BMSCs, a high VEGF secretion was demonstrated by ELISA; and typical tubular structures were observed in culture plastics. We conclude that Cu2+-doped BG scaffolds release Cu2+, which in turn act on BMSCs to secrete VEGF. This result is of significance for the application of BG scaffolds in bone tissue engineering approaches.
Calcium phosphate biocements based on calcium phosphate chemistry are well-established biomaterials for the repair of non-load bearing bone defects due to the brittle nature and low flexural strength of such cements. This article features reinforcement strategies of biocements based on various intrinsic or extrinsic material modifications to improve their strength and toughness. Altering particle size distribution in conjunction with using liquefiers reduces the amount of cement liquid necessary for cement paste preparation. This in turn decreases cement porosity and increases the mechanical performance, but does not change the brittle nature of the cements. The use of fibers may lead to a reinforcement of the matrix with a toughness increase of up to two orders of magnitude, but restricts at the same time cement injection for minimal invasive application techniques. A novel promising approach is the concept of dual-setting cements, in which a second hydrogel phase is simultaneously formed during setting, leading to more ductile cement-hydrogel composites with largely unaffected application properties.
Intraperitoneal adhesions are fibrous bands that connect tissues in the peritoneal cavity that are usually separated. These adhesions form as a consequence of trauma, inflammation or surgical interventions and often result in severe consequences such as chronic pain, small bowel obstructions or female infertility.
The aim of this thesis was to develop a synthetic barrier device for adhesion prevention made of modified poly(lactide) [PLA]. Solid PLA films (SurgiWrap®) are already successfully in clinical use due to the good biocompatibility and the biodegradability of the material resulting in non-toxic degradation products since lactic acid is naturally part of the metabolic circles of the human body. Considering the brittleness and stiffness of the films, the long degradation time of several months as well as the need for suturing, there is potential for optimization. Through a copolymerization with the hydrophilic poly(ethylene glycol) [PEG], a reduction of the degradation time was intendend. Moreover, the copolymerization should also lead to an improvement of the mechanical properties of the films since PEG acts as plasticizer for PLA. Linear PLA-PEG-PLA triblock copolymers as well as star-shaped PEG-PLA copolymers were synthesized via standard ring opening polymerization to tailor the barrier properties. Besides solid films, solution electrospun meshes from PLA and the synthesized PEG-PLA copolymers were investigated for a potential application as well. Since suturing of a barrier additionally induces adhesion formation, alginate coated membranes were prepared in order to achieve self-adhesiveness. With the intention to reduce infections and consequently inflammation, electrospun meshes and solvent cast films were loaded with the antibacterial drug triclosan and drug release as well as antibacterial efficacy was investigated.
Mechanical tests confirmed that through the variation of the PEG content and branching the mechanical properties can be tailored and are in good accordance with the glass transition temperatures [Tg] of the polymers. Consequently, potentially adequate mechanical properties for surgical handling as well as for the performance within the patient’s body were successfully achieved. Degradation studies revealed that the degradation time was significantly shorter for PEG-PLA membranes than for PLA films and with an appropriate PEG content could be adjusted to the intended time frame. Cell adhesion and viability tests confirmed the non-toxicity of the clinically used PLA films as well as of PEG-PLA films and meshes. With a bioadhesion test the benefit of an alginate coated side towards the pure PLA film concerning self-adhesiveness was successfully demonstrated. Moreover, optical evaluations and a T-peel test of different alginate coated PLA films showed that the cohesion between the chemically different layers was distinctly enhanced by the use of an appropriate PEG-PLA mesh as intermediate cohesion promoting layer. In in vitro release studies with triclosan loaded films a higher release was determined for PEG-PLA than for PLA films. In agar diffusion tests a higher and longer inhibition of staphylococcus aureus growth was observed confirming the release results. Moreover, drug loaded meshes (especially drug loaded after electrospinning) showed enhanced and elongated bacterial inhibition in comparison to films.
Additive manufacturing of scaffolds with sub-micron filaments via melt electrospinning writing
(2015)
The aim of this study was to explore the lower resolution limits of an electrohydrodynamic process combined with direct writing technology of polymer melts. Termed melt electrospinning writing, filaments are deposited layer-by-layer to produce discrete three-dimensional scaffolds for in vitro research. Through optimization of the parameters (flow rate, spinneret diameter, voltage, collector distance) for poly-ϵ-caprolactone, we could direct-write coherent scaffolds with ultrafine filaments, the smallest being 817 ± 165 nm. These low diameter filaments were deposited to form box-structures with a periodicity of 100.6 ± 5.1 μm and a height of 80 μm (50 stacked filaments; 100 overlap at intersections). We also observed oriented crystalline regions within such ultrafine filaments after annealing at 55 °C. The scaffolds were printed upon NCO-sP(EO-stat-PO)-coated glass slide surfaces and withstood frequent liquid exchanges with negligible scaffold detachment for at least 10 days in vitro.